Unitaid

Hepatitis C can be cured. So why are so many people still unable to access the care they need? Unitaid is investing an additional US$7.8 million to expand prevention and treatment for people who inject drugs across 10 countries. Find out more:

What does it take to turn promising #Ebola innovations into accessible tools? Unitaid’s investment of up to US$3.4M supports preparations to help countries access new Bundibugyo #Ebola diagnostics and treatments, should they prove safe and effective.

How can long-acting HIV prevention reach more people? In Tshwane, South Africa, @UNITAID visited Maria Rantho Clinic and a mobile clinic serving a local hotspot area to learn about @WitsRHI's LEN4PrEP study and community-based HIV prevention.

#AI could close the global health gap. Or widen it. Our new publication explores how to make AI more equitable and turn innovation into access. Read more:

“It is a silent disease,” says Unitaid’s Janet Ginnard. Women may not know they’re infected until complications emerge. SAFEStart+ is a $22m initiative working to prevent HIV, syphilis, hepatitis B and Chagas disease passing from mother to baby.

The next pandemic won’t wait. We can’t afford to be unprepared. The Republic of Korea is backing Unitaid with US$13 million in 2026 to expand access to lifesaving health innovations, strengthen diagnostics and build pandemic preparedness.

Preeclampsia can become life-threatening quickly, yet many women still struggle to access timely diagnosis and treatment. A new @WHO global roadmap aims to accelerate action. The priority now is ensuring life-saving care reaches every woman who needs it:

“We survived for different reasons. One of us because oxygen was guaranteed, the other because crowdfunding intervened.” Louis and Maurine’s stories expose inequalities in access to life-saving oxygen. Read more:

Heat-stable carbetocin costs more than oxytocin. Could it save health systems money? Research from Uganda estimates it could prevent nearly one-third more cases of postpartum hemorrhage, with potential savings of US$1M in direct public health system costs:

TB pooled testing could cut diagnosis costs by 50%. @UNITAID shaped and funded research with @LSTMnews and partners to explore this approach. Listen to the discussion on @BBCSounds, from 12 mins:

“Where you live still determines whether you will live.” Preeclampsia survivor and advocate Koiwah Koi-Larbi explains why life-saving care must reach every woman.

Preeclampsia is a leading cause of maternal & newborn deaths. We have tools to prevent, detect and treat it, but they don’t always reach the women who need them. @UNITAID & partners are working to change that through a new global roadmap @HRPresearch @WHO

RT @Jhpiego: When it comes to #PPH, we need to look beyond the numbers and ask ourselves, ‘How can we scale what we can’t see?’ Strengthening routine PPH data is essential to understanding the challenge, tracking progress, and driving action. #WorldPPHDay

RT @Jhpiego: On #WorldPPHDay, we’re reminded that every minute matters. Sunita Bai’s story shows what’s possible when frontline providers have the tools, training and confidence to act when it matters most. Read her story:

“Without access to innovation, we create injustice.” For Dr. Serge Breysee, innovation, access and impact go hand in hand. Watch the full discussion with leading voices in global health.

Congenital syphilis is preventable, but getting proven, low-cost tools to women in time remains a challenge. In a new @devex article, @UNITAID Director of Strategy discusses what it takes to make congenital syphilis prevention routine, country-led care:

Postpartum haemorrhage can become life-threatening within minutes. On #WorldPPHDay, Dr. Mary Maina shares how Kenya is testing innovations to help health workers prevent, detect and treat it sooner.

Louis and Maurine both needed oxygen during COVID-19. In Portugal, Louis received it continuously for two weeks. In Kenya, Maurine had to raise money to access it. Why does access to a century-old essential therapy still depend on where you live?

RT @CHAI_health: A year ago, we announced a deal to bring lenacapavir, a twice-yearly HIV prevention shot, to 120 LMICs for US$40. Now the focus is delivery. CHAI CEO Buddy Shah joined @AlterIgoe on @devex Theory of Change at #UNGA81. @drreddys | @UNITAID | @WitsRHI

Making TB diagnosis more affordable, and bringing it closer to people who need it. Unitaid investments are helping make it possible: Pooled testing: 50% lower costs Portable X-ray + AI: 65% lower costs, helping reach remote communities. @LSTMnews @katlay @LancetGH @CHAI_health

While most advances in fighting TB come with a large price tag, the shift in strategy could dramatically boost access to diagnosis and save money, experts said ⤵️